STOCK TITAN
  1. Home
  2. Sec-filings
  3. EQIX
  4. [Form 4] EQUINIX INC Insider Trading Activity

Equinix (EQIX) CFO sells 2,422 shares to cover RSU tax obligations

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Equinix Inc.’s Chief Financial Officer Keith D. Taylor reported multiple transactions in company equity. On February 18, 2026, he executed open-market sales totaling 2,422 shares of common stock at weighted-average prices ranging from roughly $926 to $944 per share, leaving 26,747.3 shares of common stock held directly afterward. A footnote explains these sales were made under a Rule 10b5-1 trading plan to raise cash for required tax withholding tied to restricted stock unit (RSU) vesting.

On February 17, 2026, Taylor acquired common shares through RSU activity, including the conversion of 1,096, 1,111, and 2,397 RSUs into common stock at a price of $0.00 per share, as well as a new grant of 4,793 RSUs. Footnotes describe these performance-based RSUs vesting over several years, subject to continued service and achievement of AFFO, revenue, and EBITDA targets.

Positive

  • None.

Negative

  • None.
Insider TAYLOR KEITH D
Role Chief Financial Officer
Sold 2,422 shs ($2.26M)
Type Security Shares Price Value
Sale Common Stock 120 $926.6696 $111K
Sale Common Stock 542 $927.8903 $503K
Sale Common Stock 120 $928.5837 $111K
Sale Common Stock 120 $929.69 $112K
Sale Common Stock 195 $930.5492 $181K
Sale Common Stock 125 $932.0277 $117K
Sale Common Stock 159 $934.0096 $149K
Sale Common Stock 81 $934.9146 $76K
Sale Common Stock 40 $937.4275 $37K
Sale Common Stock 252 $938.9004 $237K
Sale Common Stock 108 $939.7991 $101K
Sale Common Stock 240 $941.6904 $226K
Sale Common Stock 160 $942.68 $151K
Sale Common Stock 160 $943.86 $151K
Exercise Restricted Stock Unit 1,096 $0.00 --
Exercise Restricted Stock Unit 1,111 $0.00 --
Grant/Award Restricted Stock Unit 4,793 $0.00 --
Exercise Restricted Stock Unit 2,397 $0.00 --
Exercise Common Stock 1,096 $0.00 --
Exercise Common Stock 1,111 $0.00 --
Exercise Common Stock 2,397 $0.00 --
Holdings After Transaction: Common Stock — 28,889.3 shares (Direct); Restricted Stock Unit — 0 shares (Direct)
Footnotes (1)
  1. 32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026. Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.03 to $926.93, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 15 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.23 to $928.21 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.35 to $929.26 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.36 to $930.31 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.37 to $931.12 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.57 to $932.39 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.42 to $934.32 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.46 to $935.37 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.35 to $937.52 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.40 to $939.34 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $939.45 to $940.32 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.41 to $942.41 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.61 to $942.89 inclusive. On February 14, 2023, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2023. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 12, 2024, 25% will vest on February 15, 2025 and the remaining 25% will vest on February 15, 2026, subject solely to continued service. Restricted stock unit award expires upon reporting person's termination of service. On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service. On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TAYLOR KEITH D
(Last) (First) (Middle)
C/O EQUINIX
ONE LAGOON DRIVE
(Street)
REDWOOD CITY CA 94065
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EQUINIX INC [ EQIX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/17/2026 M 1,096 A $0 25,501.3(1) D
Common Stock 02/17/2026 M 1,111 A $0 26,612.3 D
Common Stock 02/17/2026 M 2,397 A $0 29,009.3 D
Common Stock 02/18/2026 S(2) 120 D $926.6696(3) 28,889.3 D
Common Stock 02/18/2026 S(2) 542 D $927.8903(4) 28,347.3 D
Common Stock 02/18/2026 S(2) 120 D $928.5837(5) 28,227.3 D
Common Stock 02/18/2026 S(2) 120 D $929.69(6) 28,107.3 D
Common Stock 02/18/2026 S(2) 195 D $930.5492(7) 27,912.3 D
Common Stock 02/18/2026 S(2) 125 D $932.0277(8) 27,787.3 D
Common Stock 02/18/2026 S(2) 159 D $934.0096(9) 27,628.3 D
Common Stock 02/18/2026 S(2) 81 D $934.9146(10) 27,547.3 D
Common Stock 02/18/2026 S(2) 40 D $937.4275(11) 27,507.3 D
Common Stock 02/18/2026 S(2) 252 D $938.9004(12) 27,255.3 D
Common Stock 02/18/2026 S(2) 108 D $939.7991(13) 27,147.3 D
Common Stock 02/18/2026 S(2) 240 D $941.6904(14) 26,907.3 D
Common Stock 02/18/2026 S(2) 160 D $942.68(15) 26,747.3 D
Common Stock 02/18/2026 S(2) 160 D $943.86 26,587.3 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit $0 02/17/2026 M 1,096 (16) (17) Common Stock 1,096 $0 0 D
Restricted Stock Unit $0 02/17/2026 M 1,111 (18) (17) Common Stock 1,111 $0 1,111 D
Restricted Stock Unit $0 02/17/2026 A 4,793 (19) (17) Common Stock 4,793 $0 4,793 D
Restricted Stock Unit $0 02/17/2026 M 2,397 (19) (17) Common Stock 2,397 $0 2,396 D
Explanation of Responses:
1. 32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026.
2. Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.03 to $926.93, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 15 to this Form 4.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.23 to $928.21 inclusive.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.35 to $929.26 inclusive.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.36 to $930.31 inclusive.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.37 to $931.12 inclusive.
8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.57 to $932.39 inclusive.
9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.42 to $934.32 inclusive.
10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.46 to $935.37 inclusive.
11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.35 to $937.52 inclusive.
12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.40 to $939.34 inclusive.
13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $939.45 to $940.32 inclusive.
14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.41 to $942.41 inclusive.
15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.61 to $942.89 inclusive.
16. On February 14, 2023, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2023. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 12, 2024, 25% will vest on February 15, 2025 and the remaining 25% will vest on February 15, 2026, subject solely to continued service.
17. Restricted stock unit award expires upon reporting person's termination of service.
18. On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service.
19. On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.
/s/ Samantha Lagocki, POA 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Equinix (EQIX) report for its CFO?

Equinix reported that CFO Keith D. Taylor sold 2,422 shares of common stock in multiple open-market trades and received several common shares via restricted stock unit conversions and a new 4,793 RSU grant, all in February 2026.

How many Equinix (EQIX) shares did the CFO sell and at what prices?

The CFO sold a total of 2,422 common shares on February 18, 2026 at weighted-average prices that, per detailed footnotes, ranged from about $926.03 to $942.89 per share across multiple individual trades.

Why did Equinix’s CFO sell shares according to the Form 4 footnotes?

A footnote states the CFO’s shares were sold under a Rule 10b5-1 trading plan to raise funds to pay required withholding taxes related to the vesting of restricted stock units, indicating a tax-driven rather than discretionary liquidity sale.

How many Equinix (EQIX) shares does the CFO hold after these transactions?

After the reported transactions, the Form 4 shows the CFO holding 26,747.3 shares of Equinix common stock directly. This reflects both the 2,422 shares sold and the common shares obtained through RSU conversions during February 2026.

What new restricted stock units did the Equinix CFO receive?

On February 17, 2026, the CFO received a new award of 4,793 restricted stock units (RSUs). Footnotes explain these performance-based RSUs vest over several years, contingent on continued service and specific AFFO, revenue, and EBITDA performance targets being met.

How are the Equinix CFO’s performance RSUs scheduled to vest?

Footnotes describe multiple performance RSU grants, each with tranches vesting over three years. After Compensation Committee certification of 2023–2025 AFFO, revenue, and EBITDA targets, portions vested in 2024–2026, with remaining tranches scheduled to vest in 2027 and 2028, subject to continued service.